Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients

NCT01880931 is registered in ClinicalTrials.gov with Severance Hospital as lead sponsor.

NCT NCT01880931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01880931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients
Lead sponsor
Severance Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2013
Completion date
November 30, 2014
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intubation, intratracheal